Ligand Pharmaceuticals (LGND) Amortizatization of Intangibles (2015 - 2026)

Ligand Pharmaceuticals has disclosed Amortizatization of Intangibles across 12 years of filings, most recently posting $1.5 million for Q1 2026.

• Amortizatization of Intangibles for Q1 2026 came in at $1.5 million, up 79.02% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.6 million (up 179.23% YoY), and the FY2025 annual result was $5.0 million, up 272.5% from the prior year.
• Amortizatization of Intangibles came in at $1.5 million for Q1 2026 at Ligand Pharmaceuticals, down from $2.0 million in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $2.0 million in Q4 2025 to a low of -$51000.0 in Q1 2022.
• The 5-year median for Amortizatization of Intangibles is $377000.0 (2023), against an average of $534882.4.
• Across the five-year window, Amortizatization of Intangibles slumped 82.93% in 2022 and soared 5285.71% in 2023, its largest moves.
• Ligand Pharmaceuticals' Amortizatization of Intangibles stood at $59000.0 in 2022, then surged by 544.07% to $380000.0 in 2023, then surged by 59.47% to $606000.0 in 2024, then jumped by 232.51% to $2.0 million in 2025, then decreased by 25.46% to $1.5 million in 2026.
• The last three Amortizatization of Intangibles figures came in at $1.5 million (Q1 2026), $2.0 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.